Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 193.96M | 4.98 | $ 38.94M |
3/31/2025 | $ 223.39M | 5.12 | $ 43.64M |
12/31/2024 | $ 160.4M | 3.94 | $ 40.73M |
9/30/2024 | $ 207.45M | 4.7 | $ 44.09M |
6/30/2024 | $ 242.06M | 6.2 | $ 39.05M |
3/31/2024 | $ 274.54M | 3.82 | $ 71.87M |
12/31/2023 | $ 295.36M | 5.25 | $ 56.31M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for INHIBRX BIOSCIENCES INC is calculated as follows: AssetsC [ $ 295.36M ] / LiabilitesC [ $ 56.31M ]
(=) Current Ratio [ 5.25 ]
Minimum
Mar 31, 2024
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |